Navigation Links
VIASPACE Subsidiary Wins $786,000 U.S. Navy Contract
Date:10/21/2008

PASADENA, Calif., Oct. 21 /PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC) subsidiary Ionfinity has been awarded a $786,000 Phase II contract for its proposal entitled "Miniature Electronic Sniffer for Navy Vertical Take off Unmanned Aerial Vehicles (VTUAVs)" by the Navy's Small Business Technology Transfer (STTR) Program. This competitively selected two year contract will result in a field demonstration of high sensitivity detection and analysis capability for chemical, explosive, and illegal drug residues in the holds and storage bays of suspect vessels. In addition to developing products for the $55 billion security industry, the new sensor technology is expected to have commercial applications in environmental monitoring, agriculture and medicine.

Ionfinity's contract is to develop a sensitive miniaturized sniffer through a joint collaboration with NASA's Jet Propulsion Laboratory, Caltech, General Dynamics, Sionex, and Imaginative Technologies. This chemical sensor system consists of a new and powerful detector called a Differential Mobility Spectrometer, a novel "soft-ionization" method that does not fragment or multiply ionize-sampled specimens, and a micro-gas chromatograph for confirmation and enhanced detection capability all integrated into a compact stand-alone system. The goal of the effort is to demonstrate detection of chemical, explosive, and illegal drug residues in the holds and storage bays of suspect vessels. The device will detect chemicals and materials of interest at ppb levels after 6 seconds. The sensor will be completely self contained with respect to power and communications and only physically attach to the VTUAV for lowering into or on to the vessel of interest.

Ionfinity Chief Operating Officer, and Principal Investigator for this effort, James Weiss, reports, "This new sensor will change the paradigm used for future chemical detection and analysis, making it much more convenient, sensitive, selective and timely."

About VIASPACE: Originally founded in 1998 with the objective of transforming proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions that solve today's complex problems, VIASPACE benefits from important patent and software licenses from Caltech, which manages NASA's Jet Propulsion Laboratory. For more information, please visit our website at http://www.VIASPACE.com, or contact for Investor Relations, Dr. Jan Vandersande, Director of Communications at 800-517-8050, or IR@VIASPACE.com.

This news release includes forward-looking statements. These forward-looking statements relate to future events or our future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Such factors include the risks outlined in our periodic filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-KSB, for the fiscal year ended December 31, 2007, as well as general economic and business conditions, the ability to acquire and develop specific projects and technologies, the ability to fund operations, changes in consumer and business consumption habits, and other factors over which VIASPACE has little or no control.


'/>"/>
SOURCE VIASPACE Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary
2. Eagle Ventures Subsidiary Hydrate2O Receives 2008 Top Gear of the Year Award From ShapeYou.com
3. American Media, Inc. Provides Dial-In Information for July 30 Call With Noteholders of American Media Operations, Inc. Subsidiary
4. XL Capital Ltd Issues Statement Regarding Merrill Lynch Lawsuit Against XL Capital Assurance Inc. (XLCA) a Subsidiary of Security Capital Assurance Ltd
5. AMDL Subsidiary Donates Pharmaceuticals in China Earthquake Relief Effort
6. Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk)
7. Natural Nutrition Subsidiary InterACTIVE Nutrition Reports First Quarter Revenue of $4,189,048 (CDN) and EBITDA of $504,500 (CDN)
8. Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA
9. Natural Nutrition Renames Former Business Lending Subsidiary i-Nutrition, Inc.
10. Barrs PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange
11. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... SANTA CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... government and financial organizations, today announced it has partnered with WALLIX to ... NIST Special Publication 800-171 . , There are a number of ways to address ...
(Date:7/24/2017)... ... July 24, 2017 , ... Anyone who uses scales know they ... would a pharmacist using that same scale to dispense medication. The first example is ... These illustrations show why it is important to have the right balance for the ...
(Date:7/24/2017)... ... 24, 2017 , ... A Southern California-based author has released a new book ... she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights ... risen above. , In “Memories,” readers get a firsthand look at what Michelle has ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... how to change manufacturers future. , The agency is hammering out a game ... one of the farthest-ranging laws ever to affect FDA-regulated firms. The new law:, ...
(Date:7/24/2017)... ... 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir ... of published author, Ed Clark. Ed Clark is a church music director and ... a minister of music and worship leader for over fifty years. He has ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: